Brief: Alligator Bioscience Q2 Operating Loss Lowers To SEK 22.3 Mln
July 10 (Reuters) - Alligator Bioscience AB ATORX.ST: Q2 OPERATING LOSS SEK 22.3 MILLION VERSUS LOSS SEK 47.4 MILLION YEAR AGO Source text: ID:nMFN2cMCmj Further company coverage: ATORX.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Alligator Bioscience AB
See all newsSweden's Alligator Bioscience Q3 sales fall as R&D winds down
Brief: Alligator Bioscience Q3 EBIT SEK -19.3 Million
Brief: Alligator Bioscience Appoints Johan Gileus As CEO
Brief: Alligator Bioscience Announces Final Outcome In Rights Issue
Brief: Alligator Bioscience To Initially Receive SEK 58.8 Mln From Rights Issue